Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -4.77% is 69% above its 5-year average of -15.37%, near the high end of its 5-year range (-31.95%–3.90%).
As of the fiscal period ended Tuesday, June 30, 2026. 76.96% above its 12-month average of -20.71%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -4.77%.
RETURN ON INVESTED CAPITAL (ROIC)
-4.77%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-20.71%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-22.24%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-15.37%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-17.13%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+76.96%
CURRENT VS 3Y AVG
+78.55%
CURRENT VS 5Y AVG
+68.97%
CURRENT VS 10Y AVG
+72.15%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.66%
median of 837 covered companies
CURRENT VS SECTOR MEDIAN
+86.62%
vs the sector median at left
Tandem Diabetes Care, Inc.
Market Cap
$1.11B
Return on Invested Capital (ROIC)
-4.77%
TTM Avg
-20.71%
3Y Avg
-22.24%
5Y Avg
-15.37%
Market Cap
$1.10B
Return on Invested Capital (ROIC)
4.80%
TTM Avg
-11.69%
3Y Avg
-3.45%
5Y Avg
0.45%
Market Cap
$1.11B
Return on Invested Capital (ROIC)
-139.11%
TTM Avg
-85.10%
3Y Avg
-62.90%
5Y Avg
-49.14%
Market Cap
$1.10B
Return on Invested Capital (ROIC)
-59.76%
TTM Avg
-52.20%
3Y Avg
-44.07%
5Y Avg
-44.07%
Market Cap
$1.09B
Return on Invested Capital (ROIC)
-8.86%
TTM Avg
-9.81%
3Y Avg
-9.88%
5Y Avg
-6.15%
Market Cap
$1.09B
Return on Invested Capital (ROIC)
-42.98%
TTM Avg
-26.82%
3Y Avg
-23.95%
5Y Avg
-23.95%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
-67.73%
TTM Avg
-67.73%
3Y Avg
-67.73%
5Y Avg
-67.73%
Market Cap
$1.08B
Return on Invested Capital (ROIC)
20.18%
TTM Avg
20.20%
3Y Avg
19.35%
5Y Avg
14.75%
Market Cap
$1.13B
Return on Invested Capital (ROIC)
1.81%
TTM Avg
7.83%
3Y Avg
4.30%
5Y Avg
3.30%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tandem Diabetes Care, Inc. (TNDM) | $1.11B | -4.77% | -20.71% | -22.24% | -15.37% |
| STAAR Surgical Company (STAA)vs › | $1.10B | 4.80% | -11.69% | -3.45% | 0.45% |
| Replimune Group, Inc. (REPL)vs › | $1.11B | -139.11% | -85.10% | -62.90% | -49.14% |
| First Tracks Biotherapeutics Inc (TRAX)vs › | $1.10B | -59.76% | -52.20% | -44.07% | -44.07% |
| OPKO Health, Inc. (OPK)vs › | $1.09B | -8.86% | -9.81% | -9.88% | -6.15% |
| Bicara Therapeutics Inc. Common Stock (BCAX)vs › | $1.09B | -42.98% | -26.82% | -23.95% | -23.95% |
| Avalyn Pharma Inc. Common Stock (AVLN)vs › | $1.13B | -67.73% | -67.73% | -67.73% | -67.73% |
| IRadimed Corporation (IRMD)vs › | $1.08B | 20.18% | 20.20% | 19.35% | 14.75% |
| Harrow Health, Inc. (HROW)vs › | $1.13B | 1.81% | 7.83% | 4.30% | 3.30% |
| GoodRx Holdings, Inc. (GDRX)vs › | $1.13B | 3.72% | 3.50% | 1.32% | -2.22% |
ROIC
-4.8%
ROE
-48.6%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -4.77% |
| 2026-03-31 | -8.95% |
| 2025-12-31 | -27.83% |
| 2025-09-30 | -30.05% |
| 2025-06-30 | -31.95% |
| 2025-03-31 | -26.43% |
| 2024-12-31 | -13.02% |
| 2024-09-30 | -18.08% |
| 2024-06-30 | -18.86% |
| 2024-03-31 | -19.66% |
| 2023-12-31 | -30.79% |
| 2023-09-30 | -28.69% |
| 2023-06-30 | -30.04% |
| 2023-03-31 | -26.22% |
| 2022-12-31 | -10.46% |
| 2022-09-30 | -7.13% |
| 2022-06-30 | -0.79% |
| 2022-03-31 | 1.19% |
| 2021-12-31 | 2.87% |
| 2021-09-30 | 3.90% |
| 2021-06-30 | 2.88% |
| 2021-03-31 | 0.37% |
| 2020-12-31 | -1.30% |
| 2020-09-30 | -4.31% |
| 2020-06-30 | -5.87% |
| 2020-03-31 | -7.92% |
| 2019-12-31 | -7.38% |
| 2019-09-30 | -9.52% |
| 2019-06-30 | -16.39% |
| 2019-03-31 | -29.09% |
| 2018-12-31 | -31.88% |
| 2018-09-30 | -44.51% |
| 2018-06-30 | -45.23% |
| 2018-03-31 | -56.64% |
| 2017-12-31 | -106.21% |
| 2017-09-30 | -113.90% |
| 2017-06-30 | -121.05% |
| 2017-03-31 | -95.86% |
| 2016-12-31 | -96.46% |
| 2016-09-30 | -136.77% |
| 2016-06-30 | -80.63% |
| 2016-03-31 | -70.79% |
| 2015-12-31 | -69.98% |
| 2015-09-30 | -70.89% |
| 2015-06-30 | -61.53% |
| 2015-03-31 | -55.18% |
| 2014-12-31 | -85.62% |
| 2014-09-30 | -73.95% |
| 2014-06-30 | -58.00% |
| 2014-03-31 | -48.82% |
| 2013-12-31 | -33.49% |
| 2013-09-30 | -144.89% |
| 2013-06-30 | -92.72% |
